KB

Kailash Bhanot

Director Director DIN 00350307
DIN 00350307 First appointment Mar 2003 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2003
Shareholding value Locked Premium profile

About Kailash Bhanot

Data last updated:

Kailash Bhanot has 23 years in corporate governance. Formerly with 1 company, such as Aster Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00350307
Primary Designation Director
First Appointment 28 Mar 2003
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Nominee Director28 Mar 20031994Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aster Drugs And Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Kailash Bhanot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kailash Bhanot

Kailash Bhanot has 23 years in corporate governance. Formerly with 1 company, such as Aster Drugs And Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Kailash Bhanot is associated with 0 companies as a director.

Kailash Bhanot has expertise in General Business.

Kailash Bhanot has 23 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available